Frederick S Hagen
Login to view DISC.As President & CEO of Icogenex Bioincubator, Frederick S. Hagen has fostered 92 companies, generating over $10. 77 billion in combined value. A graduate of the University of Washington (Ph. D. ) and Harvard Medical School (PostDoc), he is a prolific inventor with 21 issued patents and 34 peer-reviewed publications.
He directed the project that cloned the human blood protein Factor VII, which became Novo Nordisk’s NovoSevenR, a blockbuster therapeutic with lifetime sales exceeding $25 billion.
Read the full overview →How Frederick shows up
Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Topics Frederick cares about
Work history
Media appearances
DISC profile (public)
DISC behavioral profile
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.